Reporting on the future of cancer care.
Vivan Therapeutics featured in Business Insider as top startup fuelling interest in predicitve drug discovery tech.
5 December 2022
Albion VC feature Vivan Therapeutics in their European Healthcare Market Map in the Diagnostics & Clinical Design Support category.
Vivan Therapeutics featured on 1MillionStartups Impact Calendar
3 December 2022
Vivan Therapeutics Partners with Canadian Medical Provider Gotodoctor.ca to Bring Truly Personalized Cancer Care to Market
Vivan Therapeutics Secures Expanded Drug Discovery & Development Platform From Mount Sinai Health System in New York
Could Fruit Flies Help Match Patients With Cancer Treatments?
Medicision reaches deal to provide avatar-driven precision cancer treatment
My Personal Therapeutics and Medivizor Announce a Collaboration Agreement
31 August 2020
My Personal Therapeutics to Test Fruit Fly Avatar Technology in Gastrointestinal
Cancer Patients
My Personal Therapeutics awarded grant from Innovate UK to collaborate with the NIHR – London In Vitro Diagnostic Co-operative to provide personalised treatment to patients with Gastro-Intestinal Cancer
15 July 2020
My Personal Therapeutics and Pentavere scoop funding for lung cancer digital therapeutics
My Personal Therapeutics and Acindes announce an exclusive collaboration agreement
27 April 2020
GHP News 2020 Biotechnology Awards Winners
Building avatar armies with fish and flies
24 March 2020
Silicon Valley pone en su podio a My Personal Therapeutics: tratamiento de cáncer personalizado
19 February 2020
27 January 2020
13 September 2019
Are fruit fly ‘avatars’ the next step in personalized medicine?
24 May 2019
22 May 2019
22 May 2019